000 | 02804cam a2200325 a 4500 | ||
---|---|---|---|
003 | OSt | ||
005 | 20231003150432.0 | ||
008 | 980212s1998 njua b 001 0 eng c | ||
020 | _a089603416X (alk. paper) | ||
040 |
_aBUL _cBUL _dBUL _beng _erda |
||
060 | 0 | 0 | _a1998 B-041 |
060 | 1 | 0 | _aWL 140 N494 1998 |
245 | 0 | 0 |
_aNeuroinflammation : _bmechanisms and management / _cedited by Paul L. Wood. |
260 |
_aTotowa, N.J. : _bHumana Press, _cc1998. |
||
300 |
_ax, 375 p. : _bill. ; _c26 cm. |
||
440 | 0 | _aContemporary neuroscience | |
504 | _aIncludes bibliographical references and index. | ||
505 | _aContents Part I. Microglia. 1.Roles of CNS Macrophages in Neurodegeneration P. L. Wood. 2.Inflammatory Markers in Chronic Neurodegenerative Disorders with Emphasis on Alzheimer's Disease D. G. Walker. 3.Inflammatory Markers in Stroke H. Kato. 4.Microgliosis and Impaired Cognition D. Giulian and J. Li. Part II. Acute Phase Proteins. 5.Strategies for Inhibition of Complement Activation in the Treatment of Neurodegenerative Diseases K. Spiegel M. R. Emmerling and S. R. Barnum. 6.Inflammatory Mechanisms of Alzheimer's Disease: Basic Research Clinical Studies and Future Directions J. Rogers and W. S. T. Griffin. Part III. Cytokines. 7.Role of IL- 1 in Neurodegeneration: Preclinical Findings with IL-1ra and ICE Inhibitors D. Martin G. Miller T. Neuberger J. Relton and N. Fischer. 8.Cytokines in Severe Head Injury L. Ott C. McClain S. Scheff J. Hatton and B. Young. 9.Neuroimmune Mechanisms in the Treatment of Multiple Sclerosis R. Lechtenberg. Part IV. Free Radicals. 10.Reactive Oxygen Involvement in Neurodegenerative Pathways: Causes Consequences and Potential Management with Nitrone-Based Free Radical Traps K. Hensley Q. Pye T. Tabatabaie C. A. Stewart and R. A. Floyd. 11.Utility of the 21-Aminosteroids in Spinal Cord Injury E. D. Hall. Part V. Miscellaneous Mediators. 12.The Role of Cell Adhesion Molecules in Neurological Disorders D. P. Andrew. 13.The Role of Glial Nitric Oxide in Neurotoxicity and Central Nervous System Diseases K. M. K. Boje. 14.Inducible Cyclooxygenase (COX-2): A Target for Novel Anti-Inflammatory Drugs I. W. Rodger and C.-C. Chan. | ||
650 | 0 |
_aNervous system _xDegeneration _xImmunological aspects. |
|
650 | 0 |
_aNervous system _xDegeneration _xTreatment. |
|
650 | 0 | _aAnti-inflammatory agents. | |
650 | 1 | 2 |
_aNeurodegenerative Diseases _ximmunology. |
650 | 2 | 2 |
_aNeurodegenerative Diseases _xdrug therapy. |
650 | 2 | 2 |
_aNerve Degeneration _ximmunology. |
650 | 2 | 2 |
_aInflammation _ximmunology. |
650 | 2 | 2 |
_aAnti-Inflammatory Agents _xpharmacology. |
700 | 1 | _aWood, Paul L. | |
942 |
_2ddc _cBO _hWL 140 N494 1998 _i1 _kWL 140 _mN494 1998 |
||
999 |
_c9500 _d9500 |